Alexander Vlassov

This inventor holds 14 USPTO granted patents and 1 published patent application and 6 EPO patents, primarily in RNA Interference Technology. Top assignees: Life Technologies Corporation, Applied Biosystems, LLC. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Vlassov. Retrieved from https://idiyas.com/inventor/alexander-vlassov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 62(Granted Patents)

Location History:

Austin, TX (US) (2013 - 2017)
Carlsbad, CA (US) (2018 - 2021)

Company Filing History:

8 out of 1,896

Life Technologies Corporation

patents

6 out of 532

Applied Biosystems, LLC

patents

Years Active: 2013-2021

Loading Chart...

Areas of Expertise:

siRNA Modification

Nucleic Acid Purification

Exosome Isolation

RNAi Technology

Phenotypic Effects

Biological Samples

Compositions

Methods

Inhibition

Stabilized Forms

Function Inhibition

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10900038 - siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAI, and stabilized forms thereof (2021-01-26),

2. 10731146 - Purification of nucleic acid from environmental or biological samples (2020-08-04),

3. 10329564 - siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof (2019-06-25),

4. 10023866 - Compositions and methods for inhibition of nucleic acids function (2018-07-17),

5. 9783804 - Compositions and methods for inhibition of nucleic acids function (2017-10-10),

6. 9771583 - siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAI, and stabilized forms thereof (2017-09-26),

7. 9671321 - Methods and compositions for exosome isolation (2017-06-06),

8. 9410153 - Compositions and methods for inhibition of nucleic acids function (2016-08-09),

9. 9347087 - Methods and compositions for exosome isolation (2016-05-24),

10. 9284551 - RNAi sequence-independent modification formats, and stabilized forms thereof (2016-03-15),

11. 9273312 - SiRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof (2016-03-01),

12. 9145556 - Compositions and methods for inhibition of nucleic acids function (2015-09-29),

13. 8901284 - Methods and compositions for exosome isolation (2014-12-02),

14. 8524681 - siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof (2013-09-03),

Title: The Innovative Contributions of Alexander Vlassov

Introduction

Alexander Vlassov is a prominent inventor based in Austin, TX, known for his significant contributions to the field of RNA interference and nucleic acid isolation. With a total of 14 patents, Vlassov has made remarkable advancements that have implications in biotechnology and molecular biology.

Latest Patents

Among his latest patents, Vlassov has developed siRNA sequence-independent modification formats aimed at reducing off-target phenotypic effects in RNA interference. These innovative modification formats utilize modified nucleotides to enhance the efficacy of short interfering RNA (siRNA) while minimizing unintended effects on endogenous genes. Additionally, he has created methods for purifying nucleic acid from environmental or biological samples, particularly those containing microbiome elements, which is crucial for accurate nucleic acid analysis.

Career Highlights

Vlassov has worked with notable companies such as Life Technologies Corporation and Applied Biosystems, LLC, where he has contributed to various projects that leverage his expertise in molecular biology. His work has been instrumental in advancing technologies that are essential for genetic research and therapeutic applications.

Collaborations

Throughout his career, Vlassov has collaborated with esteemed colleagues, including Nitin Puri and Susan Maylin Magdaleno, further enhancing the impact of his work in the scientific community.

Conclusion

Alexander Vlassov's innovative contributions to RNA interference and nucleic acid purification underscore his role as a leading inventor in biotechnology. His patents reflect a commitment to advancing scientific knowledge and improving methodologies in molecular biology.

Profile summary based on public USPTO records.